IONIS PHARMACEUTICALS INC — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| LOSCALZO JOSEPH | — | Sale | 13,508 | $37.86 | $511,413 | 32,251 | Nov 12, 2024 |
| Swayze Eric | EVP Research | Sale | 53 | $38.31 | $2,030 | 157 | Oct 15, 2024 |
| Swayze Eric | EVP Research | Other | 11 | $38.64 | $425 | 34,907 | Aug 30, 2024 |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | Other | 246 | $38.64 | $9,505 | 48,873 | Aug 30, 2024 |
| Monia Brett P | Chief Executive Officer | Other | 140 | $38.64 | $5,410 | 174,023 | Aug 30, 2024 |
| Geary Richard S | EVP, Chief Development Officer | Other | 11 | $38.64 | $425 | 84,834 | Aug 30, 2024 |
| Birchler Brian | EVP, Corp and Development Ops | Other | 12 | $38.64 | $464 | 46,168 | Aug 30, 2024 |
| BENNETT C FRANK | EVP, Chief Scientific Officer | Other | 177 | $38.64 | $6,839 | 79,607 | Aug 30, 2024 |
| Geary Richard S | EVP, Chief Development Officer | Sale | 320 | $49.16 | $15,731 | 85,154 | Aug 29, 2024 |
| Geary Richard S | EVP, Chief Development Officer | Sale | 2,430 | $48.00 | $116,640 | 85,508 | Aug 5, 2024 |
| KLEIN JOSEPH III | — | Option Exercise | 12,000 | $24.42 | $293,040 | 12,000 | Jul 16, 2024 |
| Diaz Allene M. | — | Sale | 900 | $48.94 | $44,046 | 16,453 | Jul 16, 2024 |
| WENDER JOSEPH H | — | Option Exercise | 4,677 | — | — | 132,756 | Jul 15, 2024 |
| PARSHALL B LYNNE | — | Option Exercise | 4,677 | — | — | 87,265 | Jul 15, 2024 |
| LOSCALZO JOSEPH | — | Option Exercise | 4,677 | — | — | 45,759 | Jul 15, 2024 |
| HERMAN JOAN E | — | Option Exercise | 4,677 | — | — | 42,007 | Jul 15, 2024 |
| BERTHELSEN SPENCER R | — | Option Exercise | 4,677 | — | — | 151,934 | Jul 15, 2024 |
| BERTHELSEN SPENCER R | — | Sale | 16,000 | $40.29 | $644,640 | 147,257 | Jun 17, 2024 |
| WENDER JOSEPH H | — | Option Exercise | 16,000 | $35.53 | $568,480 | 128,079 | May 9, 2024 |
| KLEIN JOSEPH III | — | Sale | 731 | $42.98 | $31,418 | 2,000 | May 3, 2024 |
| Baroldi Joseph | EVP, Chief Business Officer | Sale | 4,006 | $41.60 | $166,650 | 19,631 | Apr 15, 2024 |
| Birchler Brian | EVP, Corp and Development Ops | Sale | 905 | $41.66 | $37,702 | 46,156 | Apr 15, 2024 |
| Swayze Eric | Officer Level 14 | Other | 605 | $34.43 | $20,830 | 34,929 | Feb 29, 2024 |
| Monia Brett P | CEO Level 15 | Other | 538 | $34.43 | $18,523 | 174,289 | Feb 29, 2024 |
| Geary Richard S | Officer Level 14 | Other | 604 | $34.43 | $20,796 | 87,938 | Feb 29, 2024 |
| Birchler Brian | Vice President Level 14 | Other | 604 | $34.43 | $20,796 | 45,186 | Feb 29, 2024 |
| BENNETT C FRANK | Officer Level 14 | Other | 383 | $34.43 | $13,187 | 79,462 | Feb 29, 2024 |
| Monia Brett P | Chief Executive Officer | Sale | 387 | $44.49 | $17,218 | 173,751 | Feb 16, 2024 |
| Monia Brett P | Chief Executive Officer | Award / Grant | 25,372 | — | — | 177,223 | Feb 2, 2024 |
| Geary Richard S | EVP, Chief Development Officer | Award / Grant | 3,820 | — | — | 89,295 | Feb 2, 2024 |
| BENNETT C FRANK | EVP, Chief Scientific Officer | Award / Grant | 3,609 | — | — | 80,932 | Feb 2, 2024 |
| Geary Richard S | EVP, Chief Development Officer | Sale | 1,995 | $50.04 | $99,830 | 87,300 | Feb 2, 2024 |
| HOUGEN ELIZABETH L | EVP, Finance & CFO | Sale | 2,162 | $49.54 | $107,105 | 92,868 | Feb 2, 2024 |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | Sale | 1,995 | $49.67 | $99,092 | 48,627 | Feb 2, 2024 |
| Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Sale | 2,106 | $49.59 | $104,437 | 47,659 | Feb 2, 2024 |
| Swayze Eric | EVP Research | Sale | 1,940 | $49.56 | $96,146 | 34,291 | Feb 2, 2024 |
| Monia Brett P | Chief Executive Officer | Sale | 23,907 | $49.37 | $1,180,289 | 173,732 | Feb 2, 2024 |
| Cadoret-Manier Onaiza | EVP,Chf GL Pdt Str & Oper Ofc | Sale | 2,162 | $49.60 | $107,235 | 35,788 | Feb 2, 2024 |
| BENNETT C FRANK | EVP, Chief Scientific Officer | Sale | 1,885 | $49.52 | $93,345 | 79,047 | Feb 2, 2024 |
| Monia Brett P | Chief Executive Officer | Sale | 23,907 | $49.37 | $1,180,289 | 173,732 | Feb 2, 2024 |
| Swayze Eric | EVP Research | Sale | 10,773 | $52.00 | $560,196 | 32,516 | Feb 1, 2024 |
| Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Sale | 2,071 | $49.59 | $102,701 | 49,812 | Feb 1, 2024 |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | Sale | 1,961 | $49.67 | $97,403 | 48,661 | Feb 1, 2024 |
| HOUGEN ELIZABETH L | EVP, Finance & CFO | Sale | 2,125 | $49.54 | $105,273 | 92,905 | Feb 1, 2024 |
| Cadoret-Manier Onaiza | EVP, Chf GL Pdt Str & Oper Ofc | Sale | 2,125 | $49.60 | $105,400 | 35,825 | Feb 1, 2024 |
| Monia Brett P | Chief Executive Officer | Sale | 2,285 | $51.75 | $118,249 | 151,851 | Jan 25, 2024 |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | Sale | 6,450 | $51.75 | $333,788 | 46,802 | Jan 25, 2024 |
| Cadoret-Manier Onaiza | EVP, Chf GL Pdt Str & Oper Ofc | Option Exercise | 15,062 | — | — | 39,374 | Jan 17, 2024 |
| Birchler Brian | EVP, Corp and Development Ops | Option Exercise | 12,080 | — | — | 49,079 | Jan 17, 2024 |
| Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Option Exercise | 15,162 | — | — | 53,332 | Jan 17, 2024 |